From Discovery to First-in-Class: Pioneering an Orphan GPCR for Unmet Medical Needs

• Leveraging advanced computational methods to discover and verify a high-potential orphan GPCR linked to our disease of interest
• Pursuing the project against investor and industry skepticism, supported by strong clinical evidence and a differentiated indication strategy
• Presenting early clinical results from Phase I trial

Speakers:

Shuguang Yuan

Co-Founder

Alphamol Science